Chapter 1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Overview
1.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Definition
1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Status and Outlook (2017-2031)
1.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Comparison by Region (2017-2031)
1.4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Comparison by Type (2017-2031)
1.5 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Comparison by Application (2017-2031)
1.6 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Comparison by Sales Channel (2017-2031)
1.7 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Analysis by Player
2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Player (2020-2022)
2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Player (2020-2022)
2.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Analysis by Type
3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market by Type
3.1.1 Consumables
3.1.2 Services
3.1.3 Software
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Type (2017-2022)
3.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2017-2022)
3.4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Average Price by Type (2017-2022)
3.5 Leading Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Analysis by Application
4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Neurology
4.1.4 Other
4.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Analysis by Sales Channel
5.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment Analysis by Region
6.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size and CAGR by Region (2017-2031)
6.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Region (2017-2022)
6.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type
6.4.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type
6.5.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type
6.6.3 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type
6.7.3 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type
6.8.3 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Commercializing Biomarkers in Therapeutic and Diagnostic Applications Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Dako (Agilent Technologies)
7.3 Merck
7.4 BD
7.5 Abbott
7.6 Genesys Biolabs (20/20GeneSystems)
7.7 Affymetrix
7.8 Agendia
7.9 ALMAC
7.10 Arrayit
7.11 Biocartic
7.12 BG Medicine
7.13 KEGG EXPRESSION Database
7.14 Thermo Fisher
7.15 BGI
Chapter 8 Upstream and Downstream Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
8.1 Industrial Chain of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
8.2 Upstream of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
8.3 Downstream of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Chapter 9 Development Trend of Commercializing Biomarkers in Therapeutic and Diagnostic Applications (2023-2031)
9.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
